DexCom, Inc. vs Sun Life Financial Inc. Common Stock — how do they compare? DexCom, Inc. trades at $86.81 (market cap $31.51B), while Sun Life Financial Inc. Common Stock trades at $77.62 (market cap $43.44B). The key difference: Sun Life Financial Inc. Common Stock is the larger of the two by market cap, and Sun Life Financial Inc. Common Stock pays a 3.47% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Sun Life Financial Inc. Common Stock for 0 Days on average.
| DXCM | SLF | |
|---|---|---|
Market Cap | $31.51B | $43.44B |
Volume | 3,480,291 | 333,821 |
Sector | Health | Financials |
52-Week High | $92.34 | $84.07 |
52-Week Low | $54.84 | $57.60 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $30.96B | $45.17B |
Dividend Yield | — | 3.47% |
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $85.06, down 1.0% on the day, with a bullish technical signal and strong fundamental growth. Revenue reached $4.66B in 2025 with a net income margin of 17.93%, and the company has beaten EPS estimates for the last three quarters. Recent news highlights expansion in Type 2 diabetes care and executive promotions, supporting positive sentiment.
The outlook is positive with a consensus price target of $96.14, implying 13% upside. Risks include competition and reimbursement challenges, but robust earnings growth and institutional backing provide a solid foundation for long-term investors.
Sun Life Financial (SLF) trades at $77.87, up 0.69% on the day, reflecting steady momentum. The stock shows consistent earnings beats in recent quarters, with Q3 2026 results pending. Financial health is solid, with a P/E of 18.82 and robust cash flow projections for 2026. Recent strategic moves include expanding disability benefits and forming a reinsurance partnership, signaling growth initiatives.
The outlook for SLF is cautiously optimistic, supported by earnings strength and strategic expansions. Key risks include competitive pressures and macroeconomic volatility. Analyst sentiment is mixed, with a majority hold rating, suggesting potential stability but limited near-term upside. Investors should weigh solid fundamentals against sector headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Sun Life Financial Inc. is a Canada-based financial services company providing insurance, wealth and asset management, and health solutions for individuals and institutions. Its products span life, health, and disability insurance along with mutual funds and pension asset management, through operations in Canada, US, the United Kingdom, Ireland, and across Asia.
Read more on SLF →